Board Update

RNS Number : 8965N

Genus PLC

26 February 2009

 



For immediate release                                                                          26 February 2009

Genus plc 

('Genus' or 'the Company')

Board Update

Genus, a world leading animal genetics company, today announces that John Worby has been appointed as Finance Director of the Company with immediate effect.

Mr Worby replaces Martin Boden who will be leaving the Company today to pursue other opportunities.

John Worby joined the Board of the Company in September 2004 when he also became Chairman of the Audit Committee.

Genus intends to strengthen the non executive representation on the Board by recruiting a replacement Audit Committee Chairman and enhancing the international commercial experience of the Board, particularly in emerging markets. A further announcement on this matter will be made in due course.

For further information please contact:

Genus plc                                      Tel: [phone] 
John Hawkins, Chairman

Buchanan Communications        Tel: [phone]
Charles Ryland
Isabel Podda
Jennie Spivey

About Genus

Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors.

Genus' worldwide sales are made in seventy countries under the trade marks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality and use these to supply the global dairy and meat supply chain.

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network.

Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

END

 

 

BOADGGZZNKMGLZM